+Compare
AVDL
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
933M

AVDL Avadel Pharmaceuticals plc Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceutical products

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for AVDL with price predictions
08:00 PM EDT Sep 28, 2023

AVDL's Indicator enters downward trend

The Aroon Indicator for AVDL entered a downward trend on September 29, 2023. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 179 similar instances where the Aroon Indicator formed such a pattern. In of the 179 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 05, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on AVDL as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AVDL turned negative on September 05, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVDL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVDL advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

AVDL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AVDL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.519) is normal, around the industry mean (85.806). P/E Ratio (0.000) is within average values for comparable stocks, (58.734). AVDL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (3.375). AVDL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (454.545) is also within normal values, averaging (61.785).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.59B. The market cap for tickers in the group ranges from 246 to 80.1B. ZTS holds the highest valuation in this group at 80.1B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -1%. For the same Industry, the average monthly price growth was 34%, and the average quarterly price growth was 16%. INNPF experienced the highest price growth at 8,150%, while NXEN experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -35%. For the same stocks of the Industry, the average monthly volume growth was -44% and the average quarterly volume growth was 5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 71
Price Growth Rating: 59
SMR Rating: 85
Profit Risk Rating: 92
Seasonality Score: -14 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

AVDL is expected to report earnings to fall 56.83% to -35 cents per share on November 06

Avadel Pharmaceuticals plc AVDL Stock Earnings Reports
Q3'23
Est.
$-0.36
Q2'23
Missed
by $0.47
Q1'23
Missed
by $0.11
Q4'22
Missed
by $0.18
Q3'22
Missed
by $0.03
The last earnings report on August 09 showed earnings per share of -82 cents, missing the estimate of -36 cents. With 112.04K shares outstanding, the current market capitalization sits at 933.00M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
10 Earlsfort Terrace
Phone
+353 19015201
Employees
41
Web
https://www.avadel.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISGLX12.64N/A
N/A
Columbia Integrated Small Cap Gr Adv
PARNX49.59-0.03
-0.06%
Parnassus Mid Cap Growth Investor
GOFIX23.32-0.03
-0.13%
GMO Resources III
VEXMX108.84-0.20
-0.18%
Vanguard Extended Market Index Investor
CIHCX9.65-0.05
-0.52%
Cullen International High Dividend C

AVDL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVDL has been loosely correlated with SIGA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if AVDL jumps, then SIGA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVDL
1D Price
Change %
AVDL100%
-1.34%
SIGA - AVDL
38%
Loosely correlated
+0.19%
ELAN - AVDL
32%
Poorly correlated
+0.45%
ZTS - AVDL
30%
Poorly correlated
-0.02%
ACB - AVDL
29%
Poorly correlated
-1.91%
CRON - AVDL
27%
Poorly correlated
-0.74%
More

Groups containing AVDL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVDL
1D Price
Change %
AVDL100%
-1.34%
medical research
(undefined stocks)
39%
Loosely correlated
-0.74%
medical service
(undefined stocks)
38%
Loosely correlated
-0.52%
europe
(undefined stocks)
32%
Poorly correlated
-0.74%
pharmaceuticals
(undefined stocks)
32%
Poorly correlated
-0.86%
Pharmaceuticals
(undefined stocks)
0%
Poorly correlated
-0.28%
More